INTERVENTIONAL ONCOLOGY ABLATION MARKET ANALYSIS

Interventional Oncology Ablation Market, By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation ), By Indication (Liver Cancer, Kidney Cancer, Lung Cancer, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Oct 2023
Code : CMI4445
Pages :389
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Interventional Oncology Ablation Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global interventional oncology ablation market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. Increasing product approvals by regulatory authorities are contributing to the growth of the global interventional oncology ablation market in the North America region. For instance, in September 2021, Novian Health Inc. a biotechnology company was granted Breakthrough Device designation from the U.S. Food and Drug Administration for its Novilase Interstitial Laser System and its proposed indication for use in focal destruction of malignant breast tumors in adult women who seek a breast conserving procedure.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa